Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Suspension Splint, for Treating Simple and Compound Fractures of the Leg.

Chicago medical examiner·2023

Same author

Report of Surgical Cases Treated at the Battles of Pea Ridge and Prairie Grove, Ark.: Primary and Secondary Amputations, Resections, Exsections, Etc., Etc.

The Chicago medical journal·2023

Same author

A Suspension Splint, Etc.

The Chicago medical journal·2023

Same author

A Suspension Splint, for Treating Simple and Compound Fractures of the Leg.

Buffalo medical and surgical journal·2023

Same author

Method of Treating Fractures of the Olecranon Process, and Head of the Humerus.

Buffalo medical and surgical journal·2023

Same author

A Suspension of Splint, for Treating Simple and Compound Fractures of the Leg.

Atlanta medical and surgical journal·2022

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Depletion of Specific Cell Populations by Complement Depletion

Depletion of Specific Cell Populations by Complement Depletion

Published on: February 5, 2010

How does B cell depletion therapy work, and how can it be improved?

E A Clark¹, J A Ledbetter

¹Department of Immunology and National Primate Research Center, Box 357330, University of Washington, Seattle, WA 98195, USA. eclark@bart.rprc.washington.edu

Annals of the Rheumatic Diseases

|October 22, 2005

Summary

B cell depletion therapy for rheumatoid arthritis likely works through multiple mechanisms, including apoptosis and cytotoxicity, targeting specific B cell subsets. Understanding these pathways can improve treatments for autoimmune diseases.

More Related Videos

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jul 13, 2026

Depletion of Specific Cell Populations by Complement Depletion

Depletion of Specific Cell Populations by Complement Depletion

Published on: February 5, 2010

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Area of Science:

Immunology
Rheumatology
Pharmacology

Background:

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
B cell depletion therapy has emerged as a significant treatment modality for RA.
The precise mechanisms underlying B cell depletion therapy's efficacy require detailed elucidation.

Purpose of the Study:

To outline the potential mechanisms of action for B cell depletion therapy in rheumatoid arthritis.
To discuss how different mechanisms contribute to therapeutic outcomes.
To explore implications for optimizing B cell depletion strategies in autoimmune diseases.

Main Methods:

Review and synthesis of existing literature on B cell depletion mechanisms.
Analysis of proposed pathways including CD20-induced apoptosis, complement-dependent cytotoxicity (CDC), and antibody-dependent cell-mediated cytotoxicity (ADCC).
Consideration of selective B cell subset targeting.

Main Results:

B cell depletion therapy likely involves multiple mechanisms, not a single pathway.
Mechanisms such as CD20-induced apoptosis, CDC, and ADCC contribute to B cell reduction.
The relative importance of each mechanism may vary depending on the targeted B cell population.

Conclusions:

Multiple mechanisms contribute to the efficacy of B cell depletion therapy in rheumatoid arthritis.
Further understanding of these pathways can guide the development of improved therapeutic strategies.
These insights are relevant for enhancing treatments for rheumatoid arthritis and other autoimmune conditions.